The amount of shares churned at 10c, and recent low volume sell down, indicates that games are clearly being played, in my opinion.
Makes no sense that almost 200,000 million shares were bought at 10c+ for the past month, yet holders have sold for losses in the past fortnight, knowing that the company is in the best position since IPO with their FDA grant and now at a significant discount of IPO price, as well as other ongoing projects in the pipeline.. Time will tell!
DYOR, GLTAH
LDX Price at posting:
7.8¢ Sentiment: Buy Disclosure: Held
